BP, Unlilever among Investors Pouring $49M into ZeaChem, Chromatin, Agradis
by Jim Lane (Biofuels Digest) ...There’s a rumor going around the biofuels and biomaterials business that today represents one of the most difficult periods to raise capital. Apparently, the rumors did not reach ZeaChem, Chromatin or Synthetic Genomics, which this